PT. Daewoong Infion Profile
Daewoong Infion is the first biopharmaceutical factory in Indonesia, producing biological products and biosimilars from drug substances to finished products with PIC/S GMP facilities and Korean GMP facilities, Halal certified, ISO 9001:2015, ISO 14001:2015 and ISO 45001: 2018 with a production capacity that can meet market needs in Indonesia and also exports.
Providing excellent quality and affordable biological and biosimilar products for Indonesia and all over the world
-
Contribute to the development of the biological and biosimilar products
-
Contribute to the global health
-
Respected company to all stakeholders and shareholders
Research & Development
In 2018, Daewoong and Universitas of Indonesia (UI) established biopharmaceutical research center in Universitas of Indonesia, Depok, West Java for bio-analysis. Daewoong also has global research centers located in Yongin, South Korea.
Our Facility
How we can support you?
Drug Substance Manufacturing
Erythropoietin drug substance manufacturing facility start from upstream (cell culture) to downstream (purification).
PFS Filling Facility
Small volume aseptic filling for Pre-filled Syringe injection.
Laboratory Facility
Laboratory with registered Animal Quarantine Installation.